Skip to content
CB Therapeutics logo

CB Therapeutics

CB Therapeutics is a YC Summer 2018 (S18) company. Based in San Diego, CA, USA. Team of 18.

  • Cellular Agriculture
  • Biotech

About CB Therapeutics

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

CB Therapeutics engineers yeast-based fermentation to produce cannabinoids, tryptamines, and other rare alkaloids at scale, replacing crop extraction and chemical synthesis as the supply route for these compounds. Its AI-guided biosynthetic platform spans eight compound classes, including phytocannabinoids, ergolines, and peptides, running each molecule through repeated design-build-test cycles to hit target purity and consistency. The company targets both therapeutic development, addressing conditions such as depression, PTSD, and opioid addiction, and commercial ingredient supply for wellness markets.

From the Y Combinator listing

How CB Therapeutics describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Fermentation-derived natural products to solve health problems

CB Therapeutics is a synthetic biology company focused on bringing cannabinoid and tryptamine therapeutics to the clinic and commercial markets to treat depression, PTSD, opioid addiction, alcoholism, pain, and other mental health problems.

Facts

Industry
Healthcare / Healthcare -> Industrial Bio
Location
San Diego, CA, USA
Team size
18
Status
Active
Stage
Early

Founders (2)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works